X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with ACTAVIS INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ACTAVIS (US) - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   ACTAVIS
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
ACTAVIS
Dec-14
PIRAMAL ENTERPRISES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,06517,481-   
Low Rs80510,663-   
Sales per share (Unadj.) Rs383.03,147.8-  
Earnings per share (Unadj.) Rs55.1-392.8-  
Cash flow per share (Unadj.) Rs74.1288.8-  
Dividends per share (Unadj.) Rs17.500-  
Dividend yield (eoy) %1.90-  
Book value per share (Unadj.) Rs719.96,827.6-  
Shares outstanding (eoy) m172.56265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.44.5 54.6%   
Avg P/E ratio x17.0-35.8 -47.4%  
P/CF ratio (eoy) x12.648.7 25.9%  
Price / Book Value ratio x1.32.1 63.0%  
Dividend payout %31.80-   
Avg Mkt Cap Rs m161,3443,741,736 4.3%   
No. of employees `0003.821.6 17.5%   
Total wages/salary Rs m16,8980-   
Avg. sales/employee Rs Th17,472.638,750.6 45.1%   
Avg. wages/employee Rs Th4,466.90-   
Avg. net profit/employee Rs Th2,512.8-4,835.7 -52.0%   
INCOME DATA
Net Sales Rs m66,099837,013 7.9%  
Other income Rs m2,425-2,089 -116.1%   
Total revenues Rs m68,524834,924 8.2%   
Gross profit Rs m18,723107,526 17.4%  
Depreciation Rs m3,274181,244 1.8%   
Interest Rs m9,38826,401 35.6%   
Profit before tax Rs m8,485-102,208 -8.3%   
Minority Interest Rs m30-   
Prior Period Items Rs m1,5930-   
Extraordinary Inc (Exp) Rs m457-7,497 -6.1%   
Tax Rs m1,032-5,255 -19.6%   
Profit after tax Rs m9,506-104,450 -9.1%  
Gross profit margin %28.312.8 220.5%  
Effective tax rate %12.25.1 236.6%   
Net profit margin %14.4-12.5 -115.2%  
BALANCE SHEET DATA
Current assets Rs m47,488440,999 10.8%   
Current liabilities Rs m104,362321,618 32.4%   
Net working cap to sales %-86.014.3 -603.3%  
Current ratio x0.51.4 33.2%  
Inventory Days Days4158 70.0%  
Debtors Days Days5166 77.2%  
Net fixed assets Rs m26,532102,208 26.0%   
Share capital Rs m3450-   
"Free" reserves Rs m114,0240-   
Net worth Rs m124,2211,815,450 6.8%   
Long term debt Rs m75,812951,332 8.0%   
Total assets Rs m308,3563,327,123 9.3%  
Interest coverage x1.9-2.9 -66.3%   
Debt to equity ratio x0.60.5 116.5%  
Sales to assets ratio x0.20.3 85.2%   
Return on assets %6.1-2.3 -261.2%  
Return on equity %7.7-5.8 -133.0%  
Return on capital %10.0-3.0 -330.8%  
Exports to sales %17.20-   
Imports to sales %6.60-   
Net fx Rs m9,2530-   
CASH FLOW
From Operations Rs m-67,773143,731 -47.2%  
From Investments Rs m-8,768-344,148 2.5%  
From Financial Activity Rs m76,199193,361 39.4%  
Net Cashflow Rs m-342-7,055 4.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 64.08 Rs / USD

Compare PIRAMAL ENTERPRISES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PIRAMAL ENTERPRISES With: FDC LTD.  BIOCON LTD  WYETH LTD  DISHMAN PHARMA  IPCA LABS  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 22, 2017 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS